Videos
MRD2STOP: Impact of Multimodal MRD Negativity on Discontinuation of Maintenance Treatment Presented at ASH 2022
Dr. Ben Derman discusses the MRD2STOP study on the impact of multimodal MRD negativity allowing for the discontinuation of myeloma maintenance treatment
Dr. Ben Derman of the…
Videos
Are Bisphosphonates Still the Standard of Care Recommendation?
Myeloma expert Dr. Brian G.M. Durie discusses how myeloma patients can manage bone disease and the reason why treatment is recommended even to those without bone disease symptoms.
The BOTTOM LINE: …
Videos
Are Bisphosphonates Still the Standard of Care Recommendation?
Myeloma expert Dr. Brian G.M. Durie discusses how myeloma patients can manage bone disease and the reason why treatment is recommended even to those without bone disease symptoms.
The BOTTOM LINE: …
Page
For more than a decade, the International Myeloma Foundation has attended the American Society of Hematology (ASH) annual meeting, an exciting convergence of more than 30,000 health-care professionals from around the world. Explore this page to learn about the latest blood cancer research from the…
News Article
STUDIO CITY, Calif., Dec. 01, 2022 -- The International Myeloma Foundation (IMF) today announced it has been selected as a winner of the 2022 Amazon Web Services (AWS) IMAGINE Grant…
IMF Person
As the Senior Research Project Coordinator, Narmeen Shammami facilitates all aspects of contract management and research projects. Narmeen's diverse experience as Director of Operations in digital media enhanced her leadership roles within research and development. She specializes in innovative…
Audio
An Interview with Support Group Leader Carl Burgman
A Myeloma Patient’s Journey from Receiving a Myeloma Diagnosis to Leading a Support Group
In this episode of the “A Day in the Life” podcast, myeloma patient and support group leader Carl Burgman discusses his myeloma journey with the IMF…
News Article
Blenrep Withdrawal: What Myeloma Patients Need to Know
On November 22, 2022, GSK announced it has initiated the process for withdrawal of the U.S. marketing authorization for…
News Article
GSK plc (LSE/NYSE: GSK) today announced it has initiated the process for withdrawal of the US marketing authorisation for Blenrep (belantamab mafodotin-blmf) following the request of the US Food and Drug Administration (FDA). This request was based on the previously announced outcome of the DREAMM-…
IMF Person
Based in St. Petersburg, Florida, Daria Tabota joins the IMF with a wealth of digital marketing, social media, and public relations experience. As the IMF’s MarCom Associate, she is responsible for helping manage the organization’s digital assets and works with the MarCom team on social media and…
Videos
Virtual Multiple Myeloma Community Workshop A virtual multiple myeloma workshop addressing the needs specific to communities in the Pacific Northwest Region of the United States.The IMF Virtual Regional Community Workshop will include an introduction to myeloma, upfront treatments at diagnosis…
Videos
IMF Patient and Family Webinar
The IMF Patient and Family Webinar, will focus on “Understanding the New Myeloma Landscape.” The speakers for this event include:
IMF Chairman of the Board and Chief Scientific Officer Brian G.…
Videos
Speakers
Jens Hillengass, MD, PhD (Roswell Park Comprehensive Cancer Center, Buffalo, NY)
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN (Cleveland Clinic – Taussig Cancer Institute, IMF Nurse Leadership Board)
What to Expect
By attending this webinar, our…
News Article
The Creatives Against Cancer fundraising event was held on Saturday, October 8 at Brightside Studios in Phoenix, AZ. Organized by Brightside Studios owners Brad and Vanessa Kuenn, along with Brad’s sister Hillary Kuenn, the event was able to raise $6,161, with…
News Article
Paul Gater—an 8.5-year myeloma patient and a member of the San Francisco Bay Area Support Group—was nominated by the International Myeloma Foundation (IMF) in May 2021 and is currently serving as a consumer reviewer for the Congressionally Directed Medical Research Programs (CDMRP). Paul…
News Article
One of the longest running 5K run/walk fundraisers in support of the International Myeloma Foundation (IMF), the Annual Miracles for Myeloma 5K Hybrid Run/Walk, proudly celebrated its 10th anniversary this year and rightly so.
For the past nine years, the annual 5K event has raised…
News Article
STUDIO CITY, CA, OCTOBER 27, 2022—The International Myeloma Foundation (IMF) today announced the details of the recent fundraising celebration hosted by Fatima Scipione and her husband, Jimmy Scipione.
The Scip & Savor for a Cure Fundraiser was held on Saturday,…
News Article
On Tuesday, October 25, The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) approved Tecvayli™ (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma, who previously…
Audio
An Interview with Support Group Leader Valarie Traynham
A Myeloma Patient’s Journey from Receiving a Myeloma Diagnosis to Leading a Support Group
In this episode of the A Day in the Life Podcast, 7-year multiple myeloma survivor and support group leader Valarie Traynham discusses…
Videos
October 22, 2022
8:00 AM - 10:30 AM PST / 9:00 AM - 11:30 AM MDT
10:00 AM - 12:30 PM CST / 11:00 AM - 1:30 PM EST
-->Virtual Multiple Myeloma Community Workshop A virtual multiple myeloma workshop addressing the needs specific to communities in the Eastern Midwest Region of the United…
Page
Blood Cancer United Co-Pay Assistance Program Blood Cancer United's Co-Pay Assistance Program works to remove financial barriers toward the cost of…
News Article
The 4th Annual Schleicher’s Hikers 5K Walk/Run was held on Saturday, October 8 in the town of Bel Air in Harford County, MD. Sponsored by Schleicher’s Hikers and Ravens Roost #74 of Harford County, MD, the annual event was able to successfully raise $11,311 for the International Myeloma…
Page
In the U.S., African Americans are about 14% of the country's population, but they constitute about 20% of all myeloma patients. And that incidence is actually growing. This is an enormous burden, considering 1 in every 5 patients diagnosed with multiple myeloma in the U.S. is African American.…
Page
What Are Disparities in Healthcare?
For people living with multiple myeloma, disparities in healthcare can spell the difference between early diagnosis and early treatment. Understanding these preventable differences is key to bridging the gap toward achieving multiple myeloma health…
Videos
What to Know When Myeloma Relapse Occurs
Myeloma expert Dr. Brian G.M. Durie discusses what patients should do at relapse and if there are treatment options available to them.
The BOTTOM LINE: Several treatment options are available to relapsed myeloma patients.…
Videos
What Is Minimal Residual Disease (MRD)?
Myeloma expert Dr. Brian G.M. Durie discusses what MRD is, and what it means to be MRD negative.
The BOTTOM LINE: MRD at 10-6 means negative after checking a million cells, and MRD at 10-5 means negative after checking 100,…
Page
Myeloma knows no borders—people everywhere are affected by this complex disease.
Videos
M-POWER New York Virtual Webinar
Watch the Replay
Know the risks and symptoms of multiple myeloma, the most common blood cancer in African Americans, and how to get the best care.
The IMF M-Power Initiative is focused on…
News Article
CLARK, N.J., Sept. 29, 2022 -- The Annual Miracles for Myeloma 5K Hybrid Run/Walk will be celebrating its tenth anniversary this year. For the past nine years, this annual event has raised over $700,000 and has funded eight Brian D. Novis (BDN) Research Grants.…
News Article
In this article from Blood and Life Sciences Magazine, IMF's Chief Medical Officer Joseph Mikhael, MD, talks about new treatments available for multiple myeloma and how the…
Audio
You're listening to A Day in the Life Podcast, brought to you by the International Myeloma Foundation. We hope this podcast provides messages of hope and resilience, for those in the Myeloma Community and beyond.
Today we are talking to Andy Sninsky, who was diagnosed with multiple myeloma in…
Event
I will be running the Chicago marathon on October 9th to raise funds for the IMF.
Videos
Do You Know Myeloma?
During the 2022 IMF Support Group Leaders Summit, we asked patients and care providers what they wished people knew about multiple myeloma.
Videos
Common Support Needs and Coping Skills for Myeloma Patients
IMF Vice President of Support Groups Robin Tuohy will moderate a presentation by Elaine Wheat Dawson, Psy.D (City of Hope—Duarte, CA)
Dr. Elaine Wheat Dawson is a Clinical Psychologist and Assistant Clinical Professor in the…
Videos
Should Patients Consult with a Myeloma Specialist?
Myeloma expert Dr. Brian G.M. Durie discusses if it is important for patients to see a multiple myeloma specialist.
The BOTTOM LINE: Patients should consult with a myeloma expert. The IMF InfoLine can assist with finding a…
News Article
NEW YORK, Sept. 15, 2022 – The International Myeloma Foundation (IMF) today announced that it is collaborating with Memorial Sloan Kettering Cancer Center (MSK) in New York City to launch M-Power New York—a program designed to empower people to change the course of myeloma by…
Videos
Can Myeloma Progression Be Monitored Using Only Blood Testing?
Multiple myeloma expert Dr. Brian G.M. Durie discusses if blood testing can accurately monitor the disease.
The BOTTOM LINE: While bone marrow biopsy is still needed at initial diagnosis, blood testing…
Event
I hope everyone reading this will please consider donating to continue on-going research and development of new treatments to keep those battling with multiple myeloma healthy for many more years.
The next race I will be running is the United Airlines NYC Half Marathon on Sunday March 19, 2023.
News Article
On Thursday evening, September 1, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky signed off on the CDC’s recommendation to administer the updated Moderna and Pfizer-BioNTech Bivalent COVID-19 vaccines to Americans this fall,…
Videos
Are COVID-19 Prevention Measures Still Necessary?
Myeloma expert Dr. Brian G.M. Durie discusses if myeloma patients should continue practicing prevention measures to avoid contracting the COVID-19 infection.
The BOTTOM LINE: Myeloma patients should continue to…
News Article
STUDIO CITY, CA, AUGUST 31, 2022 – September is Blood Cancer Awareness Month. This year, the International Myeloma Foundation (IMF) is bringing multiple myeloma—the second most common type of blood cancer—to the forefront through its #kNOwMyeloma campaign.…
Videos
Are Myeloma Patients Being Cured With Early and Aggressive Treatment?
Myeloma expert Dr. Brian G.M. Durie discusses if newly diagnosed and high-risk smoldering myeloma patients are being cured when treated early and aggressively.
The BOTTOM LINE: Early and…
Event
I have been doing these awareness and fundraising rides concerning Multiple Myeloma since 2011. With each mile of these rides on 3 continents, I have carried this cancer in me. I do not know why it has not taken me yet, but each bicycle mile is a gift that makes me happy.
Page
Read up on CDC recommendations for the moderately or severely immunocompromised, building a personal COVID-19 plan, proper ventilation, and more.
Page
The latest news updates on COVID-19 and CDC guidelines for myeloma patients and the moderately and severely immunocompromised.
June 23, 2025
New COVID-19 Variant NB.1.81 Causes ‘Razor Blade Throat’
According to a…